LRCH2 expression was related with tumorigenesis, and over-expression of the gene involved in several carcinogenesis, including low grade of melanomas and gliomas, while LRCH2 gene expression was decreased in late stage breast cancer patients with metastasis [24]. This evidence concerns the gene LRCH2 and central nervous system cancer.